-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Corrosive Esophagitis (Erosive Esophagitis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naronapride in Corrosive Esophagitis (Erosive Esophagitis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Corrosive Esophagitis (Erosive Esophagitis) Drug Details: Naronapride is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NN-9041 in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NN-9041 in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NN-9041 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naronapride in Diabetic Gastroparesis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Naronapride in Diabetic Gastroparesis Drug Details: Naronapride is under development for the treatment of multiple...
-
Sector Analysis
Colombia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Colombia Construction Market Report Overview The Colombia construction market size was $55.1 billion in 2023. The market will garner an AAGR of more than 5% during 2025-2028. Investments in transport and energy projects will drive the sector’s growth during the projected period. Furthermore, the government’s intention to invest COP101.9 trillion ($24.9 billion) during the current presidential term (ending August 2026) to develop transportation infrastructure will propel the sector’s growth during the projected period. Colombia Construction Market Outlook, 2023-2028 ($ Billion)...
-
Company Profile
DICE Therapeutics Inc – Company Profile
DICE Therapeutics Inc (DICE Therapeutics), formerly DiCE Molecules Holdings LLC, is a pre-clinical stage biopharmaceutical company that develops drugs for the treatment of immunological and chronic diseases. The company is investigating its lead product candidate IL-17 (interleukin 17), an immune-cell-derived cytokine to treat psoriasis and other IL-17 mediated chronic immune disorders and other indications. It is also evaluating drug candidates for the treatment of inflammatory bowel disease, fibrosis and other immune-oncology disorders. The company harnesses its proprietary DELSCAPE platform technology...
Add to Basket -
Product Insights
Net Present Value Model: Tolerogenic DNA
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Tolerogenic DNA Drug Details NNC-03610041 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NN-9041
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NN-9041 Drug Details NNC-03610041 is under development for the treatment of type 1 diabetes....
-
Product Insights
Net Present Value Model: Pariet/Aciphex
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pariet/Aciphex Drug Details Rabeprazole Sodium (Aciphex,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CC-4066
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CC-4066 Drug Details CC-4066 is under development for the treatment of acute kidney injury,...